- Trials with a EudraCT protocol (81)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
81 result(s) found for: Generalized anxiety disorder.
Displaying page 1 of 5.
EudraCT Number: 2006-005674-47 | Sponsor Protocol Number: CL3-20098-050 | Start Date*: 2007-10-26 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Long-term efficacy and safety of agomelatine in non-depressed out-patients with Generalized Anxiety Disorder.A 26-week randomised double-blind placebo-controlled parallel group study following an ... | |||||||||||||
Medical condition: Generalised anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) SE (Completed) EE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001666-15 | Sponsor Protocol Number: CL3-20098-087 | Start Date*: 2013-06-11 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of 2 doses of agomelatine (10 mg/day or 25 mg/day) versus placebo given orally for 12 weeks in non depressed out-patients with Generalized Anxiety Disorder. A 12-week randomise... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SK (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002577-23 | Sponsor Protocol Number: CL2-20098-040 | Start Date*: 2004-12-08 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of Agomelatine (25 mg with potential adjustment at 50 mg) given orally once a day for 12 weeks in out-patients with Generalised Anxiety Disorder. A randomised flexible dose doub... | |||||||||||||
Medical condition: Generalised Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003421-17 | Sponsor Protocol Number: CL3-20098-051 | Start Date*: 2009-02-18 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of agomelatine (25 mg/day with potential blinded adjustment at 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, dou... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000521-61 | Sponsor Protocol Number: 750201.01.016 | Start Date*: 2007-03-12 | |||||||||||
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
Full Title: Multi-center, double-blind, randomized, reference-controlled study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with generalized anxie... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010902-13 | Sponsor Protocol Number: F1J-MC-HMGF(a) | Start Date*: 2010-08-03 | |||||||||||
Sponsor Name:LILLY S.A. | |||||||||||||
Full Title: Duloxetina versus placebo en el tratamiento de pacientes de avanzada edad con trastorno de ansiedad generalizada Duloxetine versus Placebo in the Treatment of Elderly Patients with Generalized Anx... | |||||||||||||
Medical condition: Trastorno de ansiedad generalizada Generalized anxiety disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001779-35 | Sponsor Protocol Number: 4 | Start Date*: 2013-02-15 | |||||||||||
Sponsor Name:University of Southampton | |||||||||||||
Full Title: The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder | |||||||||||||
Medical condition: Generalised anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004147-33 | Sponsor Protocol Number: EFC5895 | Start Date*: 2007-02-21 |
Sponsor Name:sanofi-aventis recherche & développement | ||
Full Title: An Eight-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Fixed Dose of SR58611A 350 mg Twice a Day in Elderly Patients with Generalized ... | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) AT (Prematurely Ended) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003181-41 | Sponsor Protocol Number: EFC5893 | Start Date*: 2005-08-16 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Recherche | |||||||||||||
Full Title: An eight-week, double-blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy, safety and tolerability of a fixed dose of SR58611A (350... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003042-47 | Sponsor Protocol Number: InsulaTOP | Start Date*: 2015-12-16 | |||||||||||
Sponsor Name:Centre Hospitalier Henri Laborit | |||||||||||||
Full Title: Psycho-biological substrates of therapeutic benefit of thermal cure on Generalized Anxiety Disorders | |||||||||||||
Medical condition: Generalised Anxiety Disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005597-67 | Sponsor Protocol Number: EFC4846 | Start Date*: 2006-03-29 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Di... | |||||||||||||
Medical condition: Major Depressive Disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003180-23 | Sponsor Protocol Number: EFC5891 | Start Date*: 2006-02-02 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: An 8-week, double blind, placebo-controlled, multicenter study with paroxetine (20 mg q24) as positive control, evaluating the efficacy and safety of 2 fixed doses of SR58611A (175 mg q12 and 350 m... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004443-11 | Sponsor Protocol Number: A5361022 | Start Date*: 2009-02-04 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A 52-WEEK OPEN-LABEL SAFETY STUDY OF PD 0332334 IN SUBJECTS WITH GENERALIZED ANXIETY DISORDER | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004768-32 | Sponsor Protocol Number: A0081147 | Start Date*: 2008-04-21 | |||||||||||
Sponsor Name:Pfizer S.A. | |||||||||||||
Full Title: “ESTUDIO DE SEGURIDAD Y EFICACIA A LARGO PLAZO DE PREGABALINA EN SUJETOS CON TRASTORNO DE ANSIEDAD GENERALIZADA” "LONG TERM SAFETY AND EFFICACY STUDY OF PREGABALIN IN SUBJECTS WITH GENERALIZED ANX... | |||||||||||||
Medical condition: Trastorno de ansiedad generalizada (TAG) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) LT (Completed) FI (Completed) AT (Completed) CZ (Completed) SI (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003699-37 | Sponsor Protocol Number: CL3-20098-089 | Start Date*: 2013-01-17 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of agomelatine (25mg/day with blinded potential adjustment to 50mg/day) versus escitalopram (10mg/day with blinded potential adjustment to 20mg/day) given orally for 12 weeks in... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DE (Completed) HU (Completed) PL (Completed) FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004006-81 | Sponsor Protocol Number: LTE5376 | Start Date*: 2006-06-01 | |||||||||||
Sponsor Name:sanofi-aventis recherche&developpement | |||||||||||||
Full Title: A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of d... | |||||||||||||
Medical condition: patients with major depressive disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) FI (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013789-17 | Sponsor Protocol Number: CL3-20098-071 | Start Date*: 2010-03-11 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Efficacy and safety of agomelatine (25 mg/day with potential blinded adjustment to 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, dou... | |||||||||||||
Medical condition: Generalized anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003643-23 | Sponsor Protocol Number: CRO-06-76 - AB/GAD/21 | Start Date*: 2006-06-14 | |||||||||||
Sponsor Name:Abiogen Pharma S.p.A. | |||||||||||||
Full Title: Efficacy and tolerability study of a novel CNS drug ABIO 08/01 administered for 8 weeks to patients with generalised anxiety disorders | |||||||||||||
Medical condition: generalised anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001673-15 | Sponsor Protocol Number: 12473A | Start Date*: 2008-09-18 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, multicentre, relapse-prevention study with Lu AA21004 in patients with Generalised Anxiety Disorder (GAD) | |||||||||||||
Medical condition: Generalised Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FR (Completed) FI (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019369-27 | Sponsor Protocol Number: ANX001-01 | Start Date*: 2010-07-23 | |||||||||||
Sponsor Name:Anxiofit Ltd. | |||||||||||||
Full Title: A Phase II randomized, double-blind, parallel-group, multi-site, placebo controlled fixed-dose study of Echinaceae angustifoliae root dry extract in 24 outpatients with generalized anxiety disorder... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
